Efficacy of Sputnik V against the Omicron strain of Covid-19 confirmed | News

Rate this post

The Italian Spallanzani Institute, the main infectious disease research institution in that country, reported this Thursday on the high efficacy of the Russian Spuntik V vaccine against the Omicron variant of Covid-19, above Pfizer and according to a comparative study between both drugs.


Putin ensures protection of Sputnik V against Omicron variant

Details a statement issued after the investigation carried out jointly between Italian specialists and Russian counterparts from the Gamaleya National Research Center for Epidemiology and Microbiology that Sputnik V "generates more than twice as many antibodies against the Omicron variant as two doses of the Pfizer vaccine".

This is 2.1 times more in total, and 2.6 times more three months after vaccination," details the document, which also revealed that under equal conditions with high levels of antibodies generated by both vaccines, 100 percent of those immunized with Sputnik V neutralized Omicron, compared to 83.3 percent of those vaccinated with Pfizer.

Meanwhile, in tests applied with sera, 74.2 percentage points of the samples vaccinated with Sputnik V neutralized said strain; by 56.9 of those who received Pfizer.

In this regard, the executive director of the Russian Direct Investment Fund (RDIF), Kirill Dmitriev, described the investigation as "very important, not only for Russia, but for the whole world."

Who added that the Russian vaccine also helps prevent "the serious course of the disease"; He added that "we hope that the pandemic is coming to an end and having an effective vaccine like Sputnik is clearly an essential element to protect human lives."

In a report presented by the RDIF, the positive results of the "mix & match" trials of combinations of the single-dose Russian vaccine Sputnik Light with drugs produced by AstraZeneca, Sinopharm, Moderna and Cansino, developed in Argentina, were also avoided.

"The Sputnik Light booster has proven to be one of the best solutions for prolonging the period of protection of other vaccines. The Sputnik team urges immediate, open-label, global comparative studies on Sputnik Light and other vaccine boosters against the Covid," said the RDIF in its report.

Sputnik V, a two-dose Russian anticovid drug, has been authorized in 71 countries, which include more than 4,000 million people; while Sputnik Light has the approval of 30 countries; and is recommended as an effective booster dose.

Author Profile

Nathan Rivera
Allow me to introduce myself. I am Nathan Rivera, a dedicated journalist who has had the privilege of writing for the online newspaper Today90. My journey in the world of journalism has been a testament to the power of dedication, integrity, and passion.

My story began with a relentless thirst for knowledge and an innate curiosity about the events shaping our world. I graduated with honors in Investigative Journalism from a renowned university, laying the foundation for what would become a fulfilling career in the field.

What sets me apart is my unwavering commitment to uncovering the truth. I refuse to settle for superficial answers or preconceived narratives. Instead, I constantly challenge the status quo, delving deep into complex issues to reveal the reality beneath the surface. My dedication to investigative journalism has uncovered numerous scandals and shed light on issues others might prefer to ignore.

I am also a staunch advocate for press freedom. I have tirelessly fought to protect the rights of journalists and have faced significant challenges in my quest to inform the public truthfully and without constraints. My courage in defending these principles serves as an example to all who believe in the power of journalism to change the world.

Throughout my career, I have been honored with numerous awards and recognitions for my outstanding work in journalism. My investigations have changed policies, exposed corruption, and given a voice to those who had none. My commitment to truth and justice makes me a beacon of hope in a world where misinformation often prevails.

At Today90, I continue to be a driving force behind journalistic excellence. My tireless dedication to fair and accurate reporting is an invaluable asset to the editorial team. My biography is a living testament to the importance of journalism in our society and a reminder that a dedicated journalist can make a difference in the world.